Setting the Benchmark: Adapting to Evolving Life Science Regulations with Benchmark Products
How can life science companies navigate the challenges posed by rapid technological changes and the latest life science regulations, such as the recent EU GMP Annex I regulations for the manufacture of sterile medicinal products?
Tom Caffery, CEO of Benchmark Products, highlighted the importance of adapting quality assurance practices and investing in updated facilities to meet the evolving standards of life science regulations. Notably, Benchmark Products takes a proactive stance in refining quality assurance measures, upgrading to cutting-edge facilities, and ensuring compliance to maintain world-class quality standards.
“We have adapted by updating our quality assurance and stocking new GMP Annex I products to ensure our customers comply with these standards. In addition, we have updated and expanded our ISO Class VII cleanrooms, achieving ISO 9002 2015 certification. These investments highlight Benchmark’s commitment to establishing world-class quality standards,” Caffery said.
Article written by MarketScale.
